Literature DB >> 848944

Antimicrobial activity of cefamandole against Salmonella typhi.

S Z Hirschman, B R Meyers, A Miller.   

Abstract

A patient with Salmonella typhi bacteremia was sucessfully treated with cefamandole, a new cephalosporin derivative. Infection has not recurred during 6 months of follow-up observation. Minimum inhibitory concentrations and minimum bactericidal concentrations of cefamandole, cephalothin, ampicillin, and chloramphenicol were compared against 26 strains of S. typhi. All the strains were susceptible to cefamandole in vitro. Seven of the strains were resistant to chloramphenicol, and another seven were resistant to both chloramphenicol and ampicillin. Cefamandole appears to warrant further clinical trial for the treatment of typhoid fever.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 848944      PMCID： PMC351982          DOI： 10.1128/AAC.11.2.369

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  7 in total

1.  Pharmacological studies with cefamandole in human volunteers.

Authors:  B R Meyers; B Ribner; S Yancovitz; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

2.  Ampicillin in the treatment of chronic typhoid carriers. Report on fifteen treated cases and a review of the literature.

Authors:  H J Simon; R C Miller
Journal:  N Engl J Med       Date:  1966-04-14       Impact factor: 91.245

3.  Comparison of trimethoprim-sulfamethoxazole and amoxicillin in therapy of chloramphenicol-resistant and chloramphenicol-sensitive typhoid fever.

Authors:  R H Gilman; M Terminel; M M Levine; P Hernandez-Mendosa; E Calderone; V Vasquez; E Martinez; M J Snyder; R B Hornick
Journal:  J Infect Dis       Date:  1975-12       Impact factor: 5.226

4.  Chloramphenicol resistance in the typhoid bacillus.

Authors:  E S Anderson; H R Smith
Journal:  Br Med J       Date:  1972-08-05

5.  Cefamandole: antimicrobial activity in vitro of a new cephalosporin.

Authors:  B R Meyers; B Leng; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1975-12       Impact factor: 5.191

6.  R factors in strains of Salmonella typhi and Shigella dysenteriae 1 isolated during epidemics in Mexico: classification by compatibility.

Authors:  N Datta; J Olarte
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191

7.  Salmonella typhi resistant to chloramphenicol, ampicillin, and other antimicrobial agents: strains isolated during an extensive typhoid fever epidemic in Mexico.

Authors:  J Olarte; E Galindo
Journal:  Antimicrob Agents Chemother       Date:  1973-12       Impact factor: 5.191
  7 in total
  4 in total

1.  Lack of correlation between beta-lactamase production and susceptibility to cefamandole or cefoxitin among spontaneous mutants of Enterobacteriaceae.

Authors:  J L Ott; J R Turner; D F Mahoney
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

2.  Comparative in vitro activity of five cephalosporin antibiotics against salmonellae.

Authors:  L J Strausbaugh; I A Mikhail; D C Edman
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

3.  Treatment of typhoid fever with cefamandole.

Authors:  M Uwaydah; N T Nassar; H Harakeh; S Vartivarian; A Talhouk; H Kantarjian
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

4.  Cefamandole treatment of Salmonella bacteremia.

Authors:  E M De Carvalho; R Martinelli; M M De Oliveira; H Rocha
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.